Extraintestinal manifestations of Crohns disease: response to infliximab (Remicade®) in the ACCENT I trial through 30 weeks

✍ Scribed by Stephen B. Hanauer; Gary R. Lichtenstein; Lloyd Mayer; Greg Keenan; Paul J. Rutgeerts

• Book ID: 119391827
• Publisher: Nature Publishing Group
• Year: 2001
• Tongue: English
• Weight: 38 KB
• Volume: 96
• Category: Article
• ISSN: 0002-9270
• DOI: 10.1016/s0002-9270(01)03720-0